Birth Control Pill Recall: Defective Packaging Could Lead To Pregnancy
WESTON, Fla. (CBS) – Apotex Corp. is recalling birth control pills because of a possible packaging error that could result in an unintended pregnancy. A recall notice on the FDA’s website says there are four recalled lots of Drospirenone and Ethinyl Estradiol tablets. The defective packaging may lead someone to miss a pill or take a placebo instead of the active tablet, raising the possibility for a “loss of efficacy.” The recalled birth control pills (Image credit: FDA) So far, there have not been any reports of unintended pregnancies. The recall affects lot numbers 7DY008A, 7DY009A, 7DY010A and 7DY011A, all with ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 5, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News FDA Recall birth control Source Type: news

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 Blister Pack/Carton Due to Possibility of Missing/Incorrect Tablet Arrangement
Weston, Florida, Apotex Corp. is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level. The four recalled lots of Drospirenone and Ethinyl Estradiol Tablets, USP may possibly contain defective blisters with incorrect tablet arrangements and/or an empty blister pocket. The affected product is manufactured by Oman Pharmaceutical Products Co. LLC. Oman under the subcontract from Helm AG, Nordkanalstrasse 28, Hamburg, 20097, Germany. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 4, 2019 Category: Food Science Source Type: news

Lo-Zumandimine (Drospirenone and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 19, 2018 Category: Drugs & Pharmacology Source Type: news

Angeliq (Drospirenone and Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 14, 2017 Category: Drugs & Pharmacology Source Type: news

Yasmin (Drospirenone and Ethinyl Estradiol) - updated on RxList
Learn about Yasmin (Drospirenone and Ethinyl Estradiol) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 21, 2017 Category: Drugs & Pharmacology Source Type: news

Safyral (Drospirenone/Ethinyl Estradiol/Levomefolate Calcium Tablets and Levomefolate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2017 Category: Drugs & Pharmacology Source Type: news

Beyaz (Drospirenone/Ethinyl Estradiol/ Levomefolate Calcium Tablets and Levomefolate Calcuim Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2017 Category: Drugs & Pharmacology Source Type: news

Yaz (Drospirenone and Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 20, 2016 Category: Drugs & Pharmacology Source Type: news

Angeliq (Drospirenone and Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 13, 2015 Category: Drugs & Pharmacology Source Type: news

EU agency sees no new risks with combined contraceptives
LONDON (Reuters) - European drug regulators said on Friday there was no reason for women to stop using combined contraceptives like Bayer's Meliane (gestodene plus ethinyl estradiol) or Yasmin (drospirenone plus ethinyl estradiol) since there was no new evidence pointing to safety risks. (Source: Modern Medicine)
Source: Modern Medicine - January 11, 2013 Category: Journals (General) Source Type: news